Abstract
Asthma is a respiratory syndrome occurring in individuals who have genetic susceptibility to develop exaggerated airway narrowing to environmental triggers. The symptoms are generally paroxysmal and typically reversible by the use of drugs relaxing airway smooth muscle (ASM). Despite considerable heterogeneity with respect to etiology, age of onset and severity, all affected individuals display some degree of airway hyperresponsiveness (AHR) upon inhalational challenge with spasmogens. ASM is undoubtedly the motor driving airway responsiveness, but whether defects in its contractile properties underlie AHR is still a matter of debate. Many non-muscle changes in asthmatic airways could contribute to AHR. However, this review focuses on the potential contributions of ASM to AHR. Several of the contractile properties of ASM are discussed, including its force-generating capacity, ability to shorten, degree of stiffness, velocity of shortening and ability to relax. The rationale for any of these individual contractile properties being involved in AHR is first explained followed by a brief summary of the current literature concerning their potential contribution to AHR in asthma.
Keywords: Adaptation, breathing, force, relaxation, shortening, stiffness, velocity, signaling, Asthma, respiratory syndrome, airway smooth muscle
Current Respiratory Medicine Reviews
Title: Airway Smooth Muscle Responsiveness: The Origin of Airway Hyperresponsiveness in Asthma?
Volume: 7 Issue: 4
Author(s): Ynuk Bosse and Peter D. Pare
Affiliation:
Keywords: Adaptation, breathing, force, relaxation, shortening, stiffness, velocity, signaling, Asthma, respiratory syndrome, airway smooth muscle
Abstract: Asthma is a respiratory syndrome occurring in individuals who have genetic susceptibility to develop exaggerated airway narrowing to environmental triggers. The symptoms are generally paroxysmal and typically reversible by the use of drugs relaxing airway smooth muscle (ASM). Despite considerable heterogeneity with respect to etiology, age of onset and severity, all affected individuals display some degree of airway hyperresponsiveness (AHR) upon inhalational challenge with spasmogens. ASM is undoubtedly the motor driving airway responsiveness, but whether defects in its contractile properties underlie AHR is still a matter of debate. Many non-muscle changes in asthmatic airways could contribute to AHR. However, this review focuses on the potential contributions of ASM to AHR. Several of the contractile properties of ASM are discussed, including its force-generating capacity, ability to shorten, degree of stiffness, velocity of shortening and ability to relax. The rationale for any of these individual contractile properties being involved in AHR is first explained followed by a brief summary of the current literature concerning their potential contribution to AHR in asthma.
Export Options
About this article
Cite this article as:
Bosse Ynuk and D. Pare Peter, Airway Smooth Muscle Responsiveness: The Origin of Airway Hyperresponsiveness in Asthma?, Current Respiratory Medicine Reviews 2011; 7 (4) . https://dx.doi.org/10.2174/157339811798281278
DOI https://dx.doi.org/10.2174/157339811798281278 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Adenosine A<sub>3</sub> Receptor: A promising therapeutic target in cardiovascular disease
Current Cardiology Reviews Rhodanine as a Privileged Scaffold in Drug Discovery
Current Medicinal Chemistry Pharma Emerging Market’s Scaning by Look and Feel of its Opportunities and Challenges
Applied Clinical Research, Clinical Trials and Regulatory Affairs Hyaluronan: The Jekyll and Hyde Molecule
Inflammation & Allergy - Drug Targets (Discontinued) Dendritic Cells for Active Anti-Cancer Immunotherapy: Targeting Activation Pathways Through Genetic Modification
Endocrine, Metabolic & Immune Disorders - Drug Targets Management of Antineutrophil Cytoplasmic Antibody Associated Vasculitis
Current Immunology Reviews (Discontinued) Interleukin-4-Induced Oxidative Stress Via Microglial NADPH Oxidase Contributes to the Death of Hippocampal Neurons In Vivo
Current Aging Science Editorial from Editor-in-Chief: Alternative and Complementary Medicine in Pulmonary Conditions
Current Respiratory Medicine Reviews Immunomodulation of the Allergic Inflammatory Response: New Developments
Inflammation & Allergy - Drug Targets (Discontinued) Auto-Antibodies As Possible Markers and Mediators of Ischemic, Dilated, and Rhythmic Cardiopathies
Current Drug Targets Synthesis of Pyrimidine-Annulated Five-Membered Heterocycles: An Overview
Current Organic Chemistry "Take and Run" and "Take and Hold" Therapeutical Electromagnetic Field Application Modalities in Physiotherapy: Some Clinically Significant Pathways of Action
Current Chemical Biology Pharmacological Approaches in the Treatment of Atrial Fibrillation
Current Medicinal Chemistry Mechanism of Idiosyncratic Drug Reactions: Reactive Metabolites Formation, Protein Binding and the Regulation of the Immune System
Current Drug Metabolism Divergent Roles of IRS (Insulin Receptor Substrate) 1 and 2 in Liver and Skeletal Muscle
Current Medicinal Chemistry Enzyme Inhibitors
Current Bioactive Compounds Anti-Angiogenetic Agents from the Sea: A New Potential Preventive and Therapeutic Wave?
Anti-Cancer Agents in Medicinal Chemistry Antihistamine Use in Dermatologic Disorders
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Novel Approaches for Inhibition of Mucus Hypersecretion in Asthma
Recent Patents on Inflammation & Allergy Drug Discovery Peptides Targeting Toll-Like Receptor Signalling Pathways for Novel Immune Therapeutics
Current Pharmaceutical Design